Use of recombinant human granulocytemacrophage colony stimulating factor in an infant with reticular dysgenesis
✍ Scribed by C. Azcona; V. Alzina; P. Barona; L. Sierrasesúmaga; I. Villa-Elízaga
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 241 KB
- Volume
- 153
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti
The hematopoietic system in patients with aplastic anemia (AA) shows both quantitative and qualitative deficiencies, i.e., reduced numbers of hematopoietic progenitor cells (HPC) and impaired HPC proliferation in long-term marrow cultures (LTMC). Since recombinant human granulocyte macrophage-colony